Both Retatrutide and copyright are innovative medications intended for treating type 2 diabetes and promoting slimming. However, they function through distinct mechanisms . Wegovy is a GLP-1 receptor site stimulator, while Zepotide acts as a dual GIP and GLP-1 agonist , potentially offering a greater impact on combined glycemic regulation and ad… Read More